Nystagmus Assessment for Patients Consulting in the Emergency Department for Acute Vertigo
NCT ID: NCT05176015
Last Updated: 2024-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
120 participants
INTERVENTIONAL
2022-01-15
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accuracy and rEliabilitY of the vEstibuLo-ocular ExAmination Performed by inteRNs IN the emerGency Department
NCT04919187
Eye-ECG Approach to Emergencies : Diagnostic Performance of the HINTS Test
NCT04118361
Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis
NCT04678167
Telemedical Examination of a Three-Component Oculomotor Testing Battery
NCT02938221
Evaluation of Nystagmus Examination Using Wearable AR Glasses in Vertigo Patients
NCT07238387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Frenzel Lens with Diagnostic Algorithm
Frenzel lens will be applied on patients' eyes during different diagnostic maneuvers to assess if a nystagmus is present and if present describe its main characteristic.
Without mentioning to patient, the emergency physician will use a diagnostic algorithm inspired from the TiTrATE approach to interpret the nystagmus and propose the need or the irrelevance for neuro-imaging
Frenzel Lens
pair of magnifying glasses (+20 dioptres) that are worn by the patient and an illuminating system. On using Frenzel goggles, the nystagmus is better seen as a result of eyes being magnified and inhibition of visual fixation.
Diagnostic Algorithm
A diagnostic algorithm using the TiTrate approach: continuous, Intermittent, trigger or spontaneous.
The diagnostic algorithm use the REDCap software that include different videos to illustrate diagnostic tests and nystagmus types. Different maneuvers: HINTS+ battery, Dix-Hallpike test, Supine Roll test.
Different Particle Repositioning Techniques will be proposed according to specific tests: Epley and Gufoni maneuvers.
Risk Score is used to assess stroke risk for transient ischaemic attack (TIA): ABCD2 and the Canadian TIA Risk Score
Frenzel Lens without Diagnostic Algorithm
Frenzel lens will be applied on patients' eyes during different diagnostic maneuvers to assess if a nystagmus is present and describe its main characteristics. No diagnostic algorithm will be used to interpret nystagmus.
Frenzel Lens
pair of magnifying glasses (+20 dioptres) that are worn by the patient and an illuminating system. On using Frenzel goggles, the nystagmus is better seen as a result of eyes being magnified and inhibition of visual fixation.
No Frenzel Lens with Diagnostic Algorithm
Nystagmus assessment in different manoeuvres is performed without the use of Frenzel lens.
Without mentioning to patient, the emergency physician will use a diagnostic algorithm inspired from the TiTrATE approach to interpret the nystagmus and propose the need or the irrelevance for neuro-imaging
Diagnostic Algorithm
A diagnostic algorithm using the TiTrate approach: continuous, Intermittent, trigger or spontaneous.
The diagnostic algorithm use the REDCap software that include different videos to illustrate diagnostic tests and nystagmus types. Different maneuvers: HINTS+ battery, Dix-Hallpike test, Supine Roll test.
Different Particle Repositioning Techniques will be proposed according to specific tests: Epley and Gufoni maneuvers.
Risk Score is used to assess stroke risk for transient ischaemic attack (TIA): ABCD2 and the Canadian TIA Risk Score
No Frenzel Lens and No Diagnostic Algorithm
The emergency physician is performing the assessment of nystagmus and its interpretation as usual. The Frenzel lens and the diagnostic algorithm are not used.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Frenzel Lens
pair of magnifying glasses (+20 dioptres) that are worn by the patient and an illuminating system. On using Frenzel goggles, the nystagmus is better seen as a result of eyes being magnified and inhibition of visual fixation.
Diagnostic Algorithm
A diagnostic algorithm using the TiTrate approach: continuous, Intermittent, trigger or spontaneous.
The diagnostic algorithm use the REDCap software that include different videos to illustrate diagnostic tests and nystagmus types. Different maneuvers: HINTS+ battery, Dix-Hallpike test, Supine Roll test.
Different Particle Repositioning Techniques will be proposed according to specific tests: Epley and Gufoni maneuvers.
Risk Score is used to assess stroke risk for transient ischaemic attack (TIA): ABCD2 and the Canadian TIA Risk Score
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be able to consent.
Exclusion Criteria
* No intoxication context
* Glycemia ≤ 3,0 mmol/L
* Only one participation is permitted
* Not able to speak adequately in French or English.
* Reachable for 3 month follow-up
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHU de Quebec-Universite Laval
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pierre La Rochelle
Chief Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre La Rochelle, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
Universite Laval
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier d'Amqui
Amqui, Quebec, Canada
Centre Hospitalier de Matane
Matane, Quebec, Canada
Centre Hospitalier de Montmagny
Saint Thomas de Montmagny, Quebec, Canada
Hopital St-Georges
Saint-Georges, Quebec, Canada
Hopital Notre-Dame-de-Fatima
Ste. Anne de la Pocatière, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MP-CIBSSSBSL-2021-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.